Valerie Kremer in Rockville Centre, New York

Home New York Rockville Centre

Valerie Kremer has Hematology/oncology as her primary medical specialty. Their primary office is: 242 Merrick Rd in Rockville Centre, New York.

They're a part of the: Mount Sinai School Of Medicine medical group which has around 139 members. You can call their office at 516-536-1455 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2010 (around 14 years of experience). They are listed as doing telehealth appointments.

Valerie Kremer Office Phone and Directions

Valerie Kremer
Mount Sinai School Of Medicine
242 Merrick Rd
Rockville Centre, New York 11570
516-536-1455

Patient Ratings
Please rate your experience with Valerie Kremer below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 516-536-1455

Enter a starting address:

Healthcare Info for Valerie Kremer

Medical School: Sorry, her university is not listed
Graduation Year: 2010
The Primary Medical Specialty for Valerie Kremer is listed as: Hematology/oncology
Approximate Years of Experience: 14
PAC (PECOS ID)#: 5092094318
NPI #: 1134445497
NPI Created On: 04/12/2010
NPI Last Updated Listed as: 03/30/2020
Primary Taxonomy Code: 207RH0003X
License Number:
270908
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Blood smear interpretation by physician with written report
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Emergency department visit, problem with significant threat to life or function
Physician telephone patient service, 21-30 minutes of medical discussion
Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Injection, denosumab, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 787912099

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $21

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783573259

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $19

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783573275

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $19

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783573287

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $19

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783573293

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835987483

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: BioOncology

Name of Drug #1: Phesgo

Open Associated Drug #1: 50242-245-01

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812759089

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: LUTATHERA

Open Associated Drug #1: 69488-003-01

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812759091

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: LUTATHERA

Open Associated Drug #1: 69488-003-01

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812759099

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: PIQRAY

Open Associated Drug #1: 0078-0708-02

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812759093

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: MEKINIST

Open Associated Drug #1: 0078-0666-15

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: TAFINLAR

Associated Drug #2: 0078-0681-66

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: TABRECTA

Name Of Drug #3: 0078-0709-56

Hematology/oncology Professionals in Rockville Centre

1.
Mary Leung

242 Merrick Rd
Rockville-centre, NY
Mount Sinai School Of Medicine

2.
Kenneth Angelino

242 Merrick Rd
Rockville-centre, NY
Mount Sinai School Of Medicine

3.
Sara Tariq

242 Merrick Rd
Rockville-centre, NY
Mount Sinai School Of Medicine

4.
Dhvani Thakker

242 Merrick Rd
Rockville-centre, NY
Mount Sinai School Of Medicine

5.
Richard Lee MD

242 Merrick Rd
Rockville-centre, NY
Mount Sinai School Of Medicine

Providers in Mount Sinai School Of Medicine

1.Anubhav Agarwal

196 Merrick Rd
Oceanside Ny 11572-1420
Mount Sinai School Of Medicine
Family Practice

2.David Aharonoff

242 Merrick Rd
Rockville Centre Ny 11570-5254
Mount Sinai School Of Medicine
Neurology

3.David Aharonoff

1 Healthy Way
Oceanside Ny 11572-1551
Mount Sinai School Of Medicine
Neurology

4.Imtiaz Ahmad

1 Healthy Way
Oceanside Ny 11572-1551
Mount Sinai School Of Medicine
Internal Medicine

5.Muhammad Ahmad

1 Healthy Way
Oceanside Ny 11572-1551
Mount Sinai School Of Medicine
Pulmonary Disease

6.Muhammad Ahmad

1 Healthy Way
Oceanside Ny 11572-1551
Mount Sinai School Of Medicine
Pulmonary Disease

View all 139 members of Mount Sinai School Of Medicine medical group